Neumora Therapeutics Inc (NMRA)

Mar 25, 2026

NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the ... - Bluefield Daily Telegraph

Mar 25, 2026

Mar 25, 2026

NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire

Mar 25, 2026

Mar 25, 2026

Does Neumora Therapeutics Inc stock have upside surprise potential2026 Levels & Consistent Growth Stock Picks - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Neumora Therapeutic (NMRA.US) will release its earnings report on March 30. - Moomoo

Mar 25, 2026

Mar 24, 2026

If You Invested $1,000 in Neumora Therapeutics Inc (NMRA) - Stock Titan

Mar 24, 2026

Mar 22, 2026

Neumora Therapeutics stock jumps, analyst sees upside in Alzheimer's treatment - MSN

Mar 22, 2026

Mar 19, 2026

NMRA SEC FilingsNeumora Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 19, 2026

Mar 18, 2026

Neumora Therapeutics (NMRA) positioned to capitalize on blockbuster opportunity - MSN

Mar 18, 2026

Mar 18, 2026

Quarterly Trades: Is Neumora Therapeutics Inc forming a breakout pattern2026 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

RBC sees upside potential in Neumora Therapeutics (NMRA) - MSN

Mar 18, 2026

Mar 18, 2026

Neumora reports promising Phase 1b results in Alzheimer’s agitation - MSN

Mar 18, 2026

Mar 17, 2026

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Short Interest Down 13.7% in February - MarketBeat

Mar 17, 2026

Mar 16, 2026

Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026 - The Manila Times

Mar 16, 2026

Mar 13, 2026

Neuropsych Drugmaker Wants Out Of Investors' IPO Data Suit - Law360

Mar 13, 2026

Mar 10, 2026

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Up 8.2%What's Next? - MarketBeat

Mar 10, 2026

Mar 09, 2026

Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity - Bitget

Mar 09, 2026

Mar 04, 2026

Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511 - Finviz

Mar 04, 2026

Mar 04, 2026

Esperion Therapeutics Inc (ESPR) Strengthens Business Outlook Amid Strategic Agreements - Bitget

Mar 04, 2026

Mar 03, 2026

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Mar 03, 2026

Mar 02, 2026

GSA Capital Partners LLP Cuts Stake in Neumora Therapeutics - National Today

Mar 02, 2026

Mar 02, 2026

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap DownTime to Sell? - MarketBeat

Mar 02, 2026

Mar 02, 2026

GSA Capital Partners LLP Cuts Position in Neumora Therapeutics, Inc. $NMRA - MarketBeat

Mar 02, 2026

Mar 01, 2026

Winners Losers: Will Neumora Therapeutics Inc benefit from geopolitical trends2025 Market WrapUp & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Mar 01, 2026

Feb 27, 2026

AlphaCore Capital LLC Has $1.16 Million Stock Holdings in Neumora Therapeutics, Inc. $NMRA - MarketBeat

Feb 27, 2026

Feb 25, 2026

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Larimar Therapeutics (LRMR) and Cigna (CI) - The Globe and Mail

Feb 25, 2026

Feb 24, 2026

Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN) and Xenon (XENE) - The Globe and Mail

Feb 24, 2026

Feb 23, 2026

Neumora Therapeutics (NMRA) Projected to Post Earnings on Monday - MarketBeat

Feb 23, 2026

Feb 21, 2026

Neumora cut to Hold at Stifel after J&J’s VENTURA exit - MSN

Feb 21, 2026

Feb 21, 2026

Can Neumora Therapeutics Inc. stock withstand economic slowdownJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru

Feb 21, 2026

Feb 21, 2026

Risk Recap: Is Telomir Pharmaceuticals Inc stock a buy or sellFed Meeting & Smart Allocation Stock Tips - baoquankhu1.vn

Feb 21, 2026

Feb 20, 2026

Neumora Therapeutics CFO Milligan sells $5119 in shares By Investing.com - Investing.com Australia

Feb 20, 2026

Feb 20, 2026

Neumora Therapeutics CFO Milligan sells $5119 in shares - Investing.com

Feb 20, 2026

Feb 19, 2026

Top Neumora Executives Quietly Cash Out in Coordinated Stock Sell-Off - TipRanks

Feb 19, 2026

Feb 19, 2026

Insider Sell Alert: Michael Milligan Sells Shares of Neumora The - GuruFocus

Feb 19, 2026

Feb 19, 2026

Neumora Therapeutics (NASDAQ:NMRA) Insider Paul Berns Sells 9,819 Shares - MarketBeat

Feb 19, 2026

Feb 19, 2026

Insider Selling: Neumora Therapeutics (NASDAQ:NMRA) Insider Sells 6,165 Shares of Stock - MarketBeat

Feb 19, 2026

Feb 18, 2026

Trading Recap: Will Neumora Therapeutics Inc stock go up in YEARTake Profit & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Feb 18, 2026

Feb 18, 2026

Neumora Therapeutics advances in novel brain-penetrant therapies - Traders Union

Feb 18, 2026

Feb 18, 2026

Neumora Therapeutics (NASDAQ:NMRA) Hits New 12-Month High Following Analyst Upgrade - MarketBeat

Feb 18, 2026

Feb 17, 2026

William Blair upgrades Neumora Therapeutics (NMRA) - MSN

Feb 17, 2026

Feb 17, 2026

William Blair Upgrades Neumora Therapeutics (NMRA) - Nasdaq

Feb 17, 2026

Feb 17, 2026

Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment - Benzinga

Feb 17, 2026

Feb 17, 2026

Neumora Therapeutics Shares Rise After William Blair Upgrade - marketscreener.com

Feb 17, 2026

Feb 17, 2026

Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up After Analyst Upgrade - MarketBeat

Feb 17, 2026

Feb 17, 2026

William Blair Upgrades Neumora Therapeutics to Outperform From Market Perform - marketscreener.com

Feb 17, 2026

Feb 17, 2026

Neumora Therapeutics (NASDAQ:NMRA) Rating Increased to Outperform at William Blair - MarketBeat

Feb 17, 2026